Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas

Pituitary

Volumn 17, Issue 6, 2014, Pages 539-545

  Verma, Jonathan ^a   McCutcheon, Ian E ^b   Waguespack, Steven G ^b   Mahajan, Anita ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Complications; Pituitary adenoma; Radiotherapy; Re irradiation; Re treatment

Indexed keywords

CAPECITABINE; CARBOPLATIN; FLUOROURACIL; TEMOZOLOMIDE; YTTRIUM 90;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CUSHING DISEASE; DISTANT METASTASIS; ENDOCRINE SURGERY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIATION THERAPY; FUNCTIONAL STATUS; GAMMA KNIFE RADIOSURGERY; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLY RECURRENT PITUITARY ADENOMA; NEOPLASM; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; PROLACTINOMA; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION INJURY; RADIATION NECROSIS; RADIOLOGICAL PROCEDURES; RETREATMENT; RETROSPECTIVE STUDY; SELLA TURCICA TUMOR; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME; TEMPORAL LOBE NECROSIS; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR REGRESSION; VITAL SIGN; ADVERSE EFFECTS; DISEASE COURSE; ENDOCRINE FUNCTION TEST; METASTASIS; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; OPTIC NERVE DISEASES; PATHOLOGY; PITUITARY NEOPLASMS; PROCEDURES; SALVAGE THERAPY; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; OPTIC NERVE DISEASES; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84912044623     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0541-x     Document Type: Article

References (28)

1. Laws ER Jr, Vance ML (1999) Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10:327–336
2. Oruckaptan HH, Senmevsim O, Ocan OE, Ozgen T (2000) Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg Neurol 53:211–219
3. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue R, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314
4. McCord MW, Buatte JM, Rennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, Grant MB, Friedman WA (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39:437–444
5. Breen P, Flickinger JC, Kondziolka D, Martinez AJ (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89:933–938
6. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Sutton ML (1990) Long-term follow-up of low-dose external pituitary irradiation for Cushing’s disease. Clin Endocrinol 33:445–455
7. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (1998) Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88:1002–1008
8. Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96:1992–2003
9. Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303–309
10. Klibanski A (2010) Clinical practice. Prolactinomas. N Engl J Med 362:1219–1226
11. Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Muller RP, Bamberg M (2002) Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178:173–186
12. Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF Jr, Pollock BE (2010) Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74:147–152
13. Mayer R, Sminia P (2008) Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 70:1350–1360
14. Danesh-Meyer HV (2008) Radiation-induced optic neuropathy. J Clin Neurosci 15:95–100
15. Sheline GE (1971) Untreated and recurrent chromophobe adenomas of the pituitary. Am J Roentgenol Radium Ther Nucl Med 112:768–773
16. Schoenthaler R, Albright NW, Wara WM, Phillips TL, Wilson CB, Larson DA (1992) Re-irradiation of pituitary adenoma. Int J Radiat Oncol Biol Phys 24:307–314
17. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089–3099
18. Noel G, Proudhom MA, Valery CA, Cornu P, Boisserie G, Hasboun D, Simon JM, Feuvrel L, Duffau H, Tep B, Delattre JY, Marsault C, Philippon J, Fohanno D, Baillet F, Mazeron JJ (2001) Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol 60:61–67
19. Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng CW, Mannarino EG, Tsai JS, Alexander E 3rd (1990) The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8:576–582
20. Maranzano E, Trippa F, Casale M, Costantini S, Anselmo P, Carletti S, Principi M, Caserta C, Loreti F, Giorgi C (2012) Reirradiation of brain metastases with radiosurgery. Radiother Oncol 102:192–197
21. Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, Reuther AM, Suh JH (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113:2198–2204
22. Lee AW, Kwong DL, Leung SF, Tung SY, Sze WM, Sham JS, Teo PM, Leung TW, Wu PM, Chappell R, Peters LJ, Fowler JF (2002) Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53:75–85
23. Lee AW, Foo W, Chappell R, Fowler JF, Sze WM, Poon YF, Law SC, Ng SH, SK O, Tung SY, Lau WH, Ho JH (1998) Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40:35–42
24. Lawrence YR, Li XA, El Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 Suppl):S20–S27
25. Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678–691
26. Harris JR, Levene MB (1976) Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120:167–171
27. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994) Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30:755–763
28. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J (2010) Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76(3 Suppl):S28–S35